Trinity Biotech PLC (NAS:TRIB)
$ 1.58 0.01 (0.64%) Market Cap: 14.96 Mil Enterprise Value: 78.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Q3 2021 Trinity Biotech PLC Earnings Call Transcript

Dec 16, 2021 / 04:00PM GMT
Release Date Price: $7.5 (-10.71%)
Operator

Good day, and welcome to the Trinity Biotech Third Quarter 2021 Financial Results Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Joe Diaz with Lytham Partners. Please go ahead.

Joe Diaz
Lytham Partners, LLC - Managing Partner

Thank you, operator, and thanks to all of you for joining us today to review the financial results of Trinity Biotech for the third quarter of 2021, which ended on September 30, 2021. Management will also discuss the entry into an $81.25 million loan facility to refinance substantially all of the existing $99.9 million of exchangeable senior notes issued by the company's subsidiary, Trinity Biotech Investment Limited and exchange agreements for over 99% of the outstanding convertible notes, all of which are subject to certain conditions received.

Joining us on today's call is Ronan O'Caoimh, Chairman and Chief Executive Officer; and John Gillard, Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot